# DoD Scleroderma, Translational Research Partnership Award

Source: https://welltoldgrants.com/grants/w81xwh-21-srp-trpa-dod-scleroderma-translational-research-partnership-award/  
Official notice: https://www.grants.gov/search-results-detail/333549

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 2 awards worth $2.4 million in total. Applications closed on September 1, 2021.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-21-SRP-TRPA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 1, 2021 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 2 |
| Total funding | $2.4 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY21 SRP TRPA mechanism supports partnerships between clinicians, research scientists and other disciplines that will accelerate the movement of promising ideas in scleroderma into clinical applications. The ultimate goal of translational research is to move a concept or observation forward into clinical application that is relevant to active-duty Service Members, Veterans, other military beneficiaries, and the American public. This award supports the development of translational research collaborations between two or more investigators to address a central problem or question in scleroderma in a manner that would be less readily achievable through separate efforts. Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or clinician’s firsthand knowledge of patients and anecdotal data. However, members of the partnership should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between basic and clinical science, reflecting an intellectual synergistic partnership between clinicians, research scientists and/or other disciplines. Applicants are encouraged to leverage resources and expertise at the National Center for Advancing Translational Sciences (NCATS) to improve efficiency and accelerate the translational process. A list of NCATS programs and resources supporting pre-clinical and clinical innovation can be found at https://ncats.nih.gov/research. The FY21 SRP TRPA requires multiple PIs. At least two, and up to three, PIs must partner in one overarching study. One partner in the collaboration must be a clinician. Multi-institutional partnerships are encouraged. At least one member of the partnership must have experience in either scleroderma research or scleroderma patient care as demonstrated by active funding and/or recent publications. A proposed project in which the partner merely supplies tissues or access to patients will not meet the intent of this award mechanism. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI(s) will be identified as a Partnering PI(s). All PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components.

## Questions people ask

### Is W81XWH-21-SRP-TRPA still open?

No. It closed on September 1, 2021. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Scleroderma, Translational Research Partnership Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Scleroderma, Translational Research Partnership Award?

Closed September 1, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $2.4 million in total across about 2 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.